The PE Ratio as of December 2025 (TTM) for Ocuphire Pharma, Inc. (OCUP) is -2.17

According to Ocuphire Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.17. This represents a change of 95.56% compared to the average of -1.11 of the last 4 quarters.

Ocuphire Pharma, Inc. (OCUP) Historical PE Ratio (quarterly & annually)

How has OCUP PE Ratio performed in the past?

The mean historical PE Ratio of Ocuphire Pharma, Inc. over the last ten years is -0.66. The current -2.17 PE Ratio has changed 32.65% with respect to the historical average. Over the past ten years (40 quarters), OCUP's PE Ratio was at its highest in in the September 2023 quarter at 1.24. The PE Ratio was at its lowest in in the June 2025 quarter at -2.01.

Ocuphire Pharma, Inc. (OCUP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ocuphire Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ocuphire Pharma, Inc. (OCUP) Average PE Ratio

How has OCUP PE Ratio performed in the past?

The current PE Ratio of Ocuphire Pharma, Inc. (OCUP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ocuphire Pharma, Inc. (OCUP) PE Ratio vs. Peers

How is OCUP’s PE Ratio compared to its peers?

Ocuphire Pharma, Inc.’s PE Ratio is greater than Grace Therapeutics, Inc. (-6.63), less than Marinus Pharmaceuticals, Inc. (-0.52), less than Lunai Bioworks Inc. (-0.24), less than Angion Biomedica Corp. (-0.27), less than Allakos Inc. (-0.42), less than LianBio (4.15), less than Liminal BioSciences Inc. (-0.03), less than Freeline Therapeutics Holdings plc (-0.29), greater than Oruka Therapeutics, Inc. (-12.14), greater than Serina Therapeutics, Inc. (-2.47),

Build a custom stock screener for Ocuphire Pharma, Inc. (OCUP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocuphire Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ocuphire Pharma, Inc. (OCUP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ocuphire Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.